Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT3A | P56704 | 16/20 | 0.59 |
| ▸ | HPGDS | O60760 | 1/20 | 0.53 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26971309 | 0.86 | HSD17B1 (0.52) | WNT3ANPC1PKMHPGDNFKB1 | |
| SCHEMBL31716043 | 0.84 | WNT3A (0.60) | WNT3AHPGDSCYP11B1SMN1; SMN2 | |
| SCHEMBL254590 | 0.79 | SRC (0.66) | WNT3AHPGDSCYP11B1RAB9A | |
| SCHEMBL16496233 | 0.78 | HPGDS (0.58) | WNT3AHPGDS | |
| SCHEMBL11990074 | 0.78 | CYP11B1 (0.58) | WNT3AHPGDSCYP11B1NPC1PKM | |
| SCHEMBL27772481 | 0.77 | WNT3A (0.59) | WNT3AHPGDS | |
| SCHEMBL12782361 | 0.77 | WNT3A (0.59) | WNT3AHPGDS | |
| SCHEMBL16495879 | 0.76 | HPGDS (0.56) | WNT3AHPGDS | |
| SCHEMBL74878 | 0.76 | SLC7A5 (0.55) | NPC1HPGDRAB9A | |
| SCHEMBL30692683 | 0.76 | SLC7A5 (0.55) | NPC1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025227032-A1 | METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES | REMIX THERAPEUTICS INC. (US) | 2025-10-30 | — | — | WO | disclosed |